Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 13, 2020

SELL
$8.5 - $15.82 $187,705 - $349,353
-22,083 Closed
0 $0
Q1 2020

May 13, 2020

BUY
$7.25 - $19.22 $160,101 - $424,435
22,083 New
22,083 $202,000
Q3 2018

Nov 14, 2018

SELL
$9.1 - $14.8 $97,370 - $158,360
-10,700 Closed
0 $0
Q2 2018

Aug 14, 2018

BUY
$9.6 - $14.6 $102,720 - $156,220
10,700 New
10,700 $104,000

Others Institutions Holding VCEL

About Vericel Corp


  • Ticker VCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,178,000
  • Market Cap $2.73B
  • Description
  • Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...
More about VCEL
Track This Portfolio

Track Capital Fund Management S.A. Portfolio

Follow Capital Fund Management S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Fund Management S.A., based on Form 13F filings with the SEC.

News

Stay updated on Capital Fund Management S.A. with notifications on news.